Broadway Financial Q3 10-Q Flags Ineffective Controls and Two Material Weaknesses
BYFC has more than doubled off its 52-week low of $5.51 on elevated volume (3.7× avg).
Summary
Broadway Financial's Q3 10-Q repeats the already-reported $392 thousand profit but newly discloses ineffective disclosure controls, two material weaknesses, and a jump in non-accrual loans to $13.7 million.
Key Events · Earnings and Guidance · BYFC
-
Q3 Profit of $392K Confirmed
Net income attributable to common stockholders was $392 thousand, or $0.04 per diluted share, versus a $24.6 million loss in Q3 2025 that included a $25.9 million goodwill impairment.
-
Disclosure Controls Deemed Ineffective
Management concluded disclosure controls and procedures were ineffective as of September 30, 2026 and identified two material weaknesses: no controls over unusual or infrequent equity-related contracts, and no controls to consider subsequent appraisals for collateral-dependent loans.
-
Credit Metrics Deteriorate
Non-accrual loans rose to $13.7 million, or 1.20% of gross loans, from $11.2 million at December 31, 2025; loans 90+ days past due rose to $9.3 million from $3.0 million.
-
Capital Ratio Slips to 12.83%
The Community Bank Leverage Ratio fell to 12.83% from 14.09% at December 31, 2025, still well above the 8.00% well-capitalized minimum.
Analysis · BYFC · Finance
The Q3 numbers were already out via the same-day 8-K: $392 thousand of net income to common ($0.04 diluted) versus a $24.6 million loss a year ago, with deposits up 21% to $1.1 billion. What is new in the 10-Q is the control environment. Management concluded disclosure controls were ineffective at September 30, 2026 and identified two material weaknesses — no controls over unusual or infrequent equity-related contracts, and no controls to consider subsequent appraisals for collateral-dependent loans. That second gap sits directly on top of a credit book that is deteriorating: non-accrual loans rose to $13.7 million (1.20% of gross loans) from $11.2 million, and loans 90+ days past due tripled to $9.3 million. Capital is still comfortably above the 8.0% CBLR well-capitalized threshold at 12.83%, but that is down from 14.09% at year-end as the balance sheet grew. For a $108 million market-cap bank, a repeat material-weakness disclosure alongside rising problem loans is the kind of governance and credit signal that can reprice the stock.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BYFC was trading at $11.62 on NASDAQ in the Finance sector, with a market capitalization of approximately $107.8M. The 52-week trading range was $5.51 to $12.35. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.